APA (7th ed.) Citation

MVS, S., LK, R., AMP, B., NC, d. R., IR, M., JPP, D. S., . . . CM, G. (2025). Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(4), 461. https://doi.org/10.1007/s40256-025-00721-4

Chicago Style (17th ed.) Citation

MVS, Sobral, et al. "Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 25, no. 4 (2025): 461. https://doi.org/10.1007/s40256-025-00721-4.

MLA (9th ed.) Citation

MVS, Sobral, et al. "Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis." American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, vol. 25, no. 4, 2025, p. 461, https://doi.org/10.1007/s40256-025-00721-4.